LATEST NEWS
TRENDING NEWS
- Funding the Future of Cancer Research: The Parker Institute for Cancer Immunotherapy Awards Nearly $3 Million to Six Early Career Researchers
- U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer
- Multimedia Plus COVID-19 Research Survey: Getting Ready For The Post Vaccine Consumer
- Northwell Delivers First Doses of Johnson & Johnson Vaccine to Patients
- IBA receives down payment from National Cancer Center Korea for a second Proteus® System
- Study underway in Nova Scotia long-term care facilities to determine health factors related to severe COVID-19 outcomes and vaccine effectiveness
- Thrive, Fight, Win: Le-Vel Goes To Battle Against Cancer
- GRAIL Announces First Health System to Offer Galleri, Novel Multi-Cancer Early Detection Blood Test
- HKBU develops dual-targeting drug for EBV-related cancers
- Dr. David Samadi’s book, The Ultimate MANual, on what men should not believe about prostate cancer
